1. Home
  2. DSM vs TCMD Comparison

DSM vs TCMD Comparison

Compare DSM & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BNY Mellon Strategic Municipal Bond Fund Inc.

DSM

BNY Mellon Strategic Municipal Bond Fund Inc.

HOLD

Current Price

$6.18

Market Cap

301.5M

Sector

Finance

ML Signal

HOLD

Logo Tactile Systems Technology Inc.

TCMD

Tactile Systems Technology Inc.

HOLD

Current Price

$30.19

Market Cap

300.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSM
TCMD
Founded
1989
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
301.5M
300.1M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
DSM
TCMD
Price
$6.18
$30.19
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$27.00
AVG Volume (30 Days)
161.7K
355.0K
Earning Date
01-01-0001
02-17-2026
Dividend Yield
3.97%
N/A
EPS Growth
N/A
18.66
EPS
N/A
0.77
Revenue
N/A
$311,513,000.00
Revenue This Year
N/A
$11.31
Revenue Next Year
N/A
$8.83
P/E Ratio
N/A
$40.08
Revenue Growth
N/A
9.28
52 Week Low
$4.69
$8.61
52 Week High
$6.05
$31.13

Technical Indicators

Market Signals
Indicator
DSM
TCMD
Relative Strength Index (RSI) 67.37 62.17
Support Level $6.00 $26.93
Resistance Level $6.05 $31.13
Average True Range (ATR) 0.06 0.93
MACD 0.01 -0.13
Stochastic Oscillator 100.00 77.62

Price Performance

Historical Comparison
DSM
TCMD

About DSM BNY Mellon Strategic Municipal Bond Fund Inc.

BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.

About TCMD Tactile Systems Technology Inc.

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Share on Social Networks: